Cuauhtemoc Licona
Chief Scientific Officer SciTherm Therapeutics
Cuauhtemoc Licona-Cassani is a prominent figure in the field of biotechnology, particularly in the development of therapeutics. He is the Director of the FEMSA Biotechnology Center and a key figure in the SciTherm Therapeutics initiative. His work focuses on creating in-silico-designed thermogenics that activate lipid and triglyceride degradation pathways, aiming to treat obesity and related metabolic diseases. Licona-Cassani’s research and development efforts are driven by a passion for understanding the life of bacteria and other microorganisms, as well as their ecological context and metabolism. His expertise in synthetic biology and functional genomics is instrumental in the discovery of microbial natural products and the development of innovative therapeutics.
Seminars
- Harnessing in-silico molecular design to engineer high-potency thermogenic candidates with superior target specificity, ensuring the activation of fat-burning pathways while avoiding the off-target cardiovascular effects common in historical thermogenic attempts
- Validating novel lipid-degradation variants through metagenomic adipocyte analysis and in-vitro lipolysis assays, providing a data-driven proof-of-concept for direct adipose tissue reduction independent of caloric intake
- Optimizing specificity for adipose tissue metabolism to inhibit lipid accumulation at the cellular level, delivering a durable metabolic solution that targets the root cause of obesity-related comorbidities
